| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,216 |
11,704 |
$660K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
9,240 |
7,799 |
$543K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,614 |
6,933 |
$527K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,451 |
6,805 |
$256K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,048 |
5,217 |
$141K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,131 |
6,829 |
$108K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,777 |
4,400 |
$67K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
550 |
516 |
$57K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
241 |
219 |
$17K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,261 |
1,134 |
$13K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
195 |
169 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
704 |
281 |
$7K |
| 87807 |
|
561 |
484 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
1,879 |
1,652 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
85 |
81 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
517 |
463 |
$2K |
| 81002 |
|
1,037 |
903 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,497 |
3,080 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
114 |
92 |
$2K |
| 84703 |
|
286 |
232 |
$1K |
| 87430 |
|
102 |
99 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
538 |
479 |
$875.39 |
| 0001A |
|
21 |
20 |
$667.14 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
916 |
784 |
$571.29 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
22 |
22 |
$420.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
51 |
47 |
$390.57 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,429 |
3,746 |
$377.28 |
| 90756 |
|
15 |
15 |
$341.85 |
| 90715 |
|
20 |
18 |
$238.32 |
| 80053 |
Comprehensive metabolic panel |
17 |
12 |
$85.50 |
| 3075F |
|
583 |
503 |
$0.00 |
| 3008F |
|
7,236 |
5,914 |
$0.00 |
| 3074F |
|
4,736 |
3,862 |
$0.00 |
| 1036F |
|
4,902 |
3,647 |
$0.00 |
| 3079F |
|
1,446 |
1,241 |
$0.00 |
| 3080F |
|
796 |
660 |
$0.00 |
| 1126F |
|
14 |
14 |
$0.00 |
| 1125F |
|
32 |
25 |
$0.00 |
| 3078F |
|
3,437 |
2,872 |
$0.00 |
| 3077F |
|
440 |
351 |
$0.00 |
| 1160F |
|
8,259 |
6,155 |
$0.00 |
| 90714 |
|
18 |
17 |
$0.00 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
27 |
26 |
$0.00 |